Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection [Phase 2]

View source ↗

Summary

A completed Phase 2 study evaluating the safety and efficacy of Celgosivir with Peginterferon alfa-2b, with or without Ribavirin, in patients with chronic Hepat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Celgosivir (celgosivir)
• Peginterferon alfa-2b (Peginterferon alfa-2b)
• Ribavirin (ribavirin)

Snippet

Sponsor: BioWest Therapeutics Inc | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED